These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 8329961)

  • 61. Prevalence of myopia between 3 months and 5 1/2 years in preterm infants with and without retinopathy of prematurity. Cryotherapy for Retinopathy of Prematurity Cooperative Group.
    Quinn GE; Dobson V; Kivlin J; Kaufman LM; Repka MX; Reynolds JD; Gordon RA; Hardy RJ; Tung B; Stone RA
    Ophthalmology; 1998 Jul; 105(7):1292-300. PubMed ID: 9663236
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Cataract surgery in children with and without retinopathy of prematurity.
    Yu YS; Kim SJ; Chang BL
    J Cataract Refract Surg; 2004 Jan; 30(1):89-94. PubMed ID: 14967273
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The treatment of advanced retinopathy of prematurity by cryotherapy and scleral buckling surgery.
    Topilow HW; Ackerman AL; Wang FM
    Ophthalmology; 1985 Mar; 92(3):379-87. PubMed ID: 2581207
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Retinopathy of prematurity in Frederiksborg County 1988-1990. A prospective investigation, an update.
    Fledelius HC
    Acta Ophthalmol Suppl (1985); 1993; (210):59-62. PubMed ID: 8329957
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Surgical therapy for stage V retinopathy of prematurity. A two-step approach.
    Trese MT
    Graefes Arch Clin Exp Ophthalmol; 1987; 225(4):266-8. PubMed ID: 3653719
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Multicenter trial of cryotherapy for retinopathy of prematurity. 3 1/2-year outcome--structure and function. Cryotherapy for Retinopathy of Prematurity Cooperative Group.
    Arch Ophthalmol; 1993 Mar; 111(3):339-44. PubMed ID: 8447743
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Long-term outcomes on lens clarity after lens-sparing vitrectomy for retinopathy of prematurity.
    Nudleman E; Robinson J; Rao P; Drenser KA; Capone A; Trese MT
    Ophthalmology; 2015 Apr; 122(4):755-9. PubMed ID: 25600197
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Treatment of retrolental fibroplasia.
    Kalina RE
    Surv Ophthalmol; 1980; 24(4):229-36. PubMed ID: 6987763
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Presumed exudative retinal detachment after cryotherapy in retinopathy of prematurity.
    Vukmer GJ; Brod RD
    Ann Ophthalmol; 1992 May; 24(5):175-6. PubMed ID: 1637126
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Lens-sparing vitrectomy for progressive tractional retinal detachments associated with stage 4A retinopathy of prematurity.
    Moshfeghi AA; Banach MJ; Salam GA; Ferrone PJ
    Arch Ophthalmol; 2004 Dec; 122(12):1816-8. PubMed ID: 15596585
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Cryotherapy for treatment of active retinopathy of prematurity: experience in London, Ontario.
    Bains RA; Cadera W; Siebert L; Han V; Kalapwrakal M
    Can J Ophthalmol; 1991 Dec; 26(7):358-60. PubMed ID: 1764640
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Prevention of cicatricial retrolental fibroplasia by cryotherapy.
    Hindle NW; Leyton J
    Can J Ophthalmol; 1978 Oct; 13(4):277-82. PubMed ID: 581747
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The incidence of ophthalmologic interventions in children with birth weights less than 1251 grams. Results through 5 1/2 years. Cryotherapy for Retinopathy of Prematurity Cooperative Group.
    Repka MX; Summers CG; Palmer EA; Dobson V; Tung B; Davis B
    Ophthalmology; 1998 Sep; 105(9):1621-7. PubMed ID: 9754167
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Comparison of the anatomical and functional outcome after laser or cryotherapy for retinopathy of prematurity (ROP)].
    Jandeck C; Kellner U; Heimann H; Foerster MH
    Ophthalmologe; 2005 Jan; 102(1):33-8. PubMed ID: 15221254
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Advanced retinopathy of prematurity. The anatomic and visual results of vitreous surgery.
    Zilis JD; deJuan E; Machemer R
    Ophthalmology; 1990 Jun; 97(6):821-6. PubMed ID: 2374688
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Anatomic success rate after 3-port lens-sparing vitrectomy in stage 4A or 4B retinopathy of prematurity.
    Lakhanpal RR; Sun RL; Albini TA; Holz ER
    Ophthalmology; 2005 Sep; 112(9):1569-73. PubMed ID: 16005974
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Late Retinal Complications in Former Preterm Infants with Regressed ROP].
    Jandeck C; Kellner U; Foerster MH
    Klin Monbl Augenheilkd; 2004 Feb; 221(2):96-100. PubMed ID: 14986207
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Anti-vascular endothelial growth factor (VEGF) drugs for treatment of retinopathy of prematurity.
    Sankar MJ; Sankar J; Mehta M; Bhat V; Srinivasan R
    Cochrane Database Syst Rev; 2016; 2():CD009734. PubMed ID: 26932750
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Plasmin enzyme-assisted vitrectomy for primary and reoperated eyes with stage 5 retinopathy of prematurity.
    Wu WC; Drenser KA; Lai M; Capone A; Trese MT
    Retina; 2008 Mar; 28(3 Suppl):S75-80. PubMed ID: 18317350
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Retinopathy of prematurity: clinical findings and current opinions on diagnosis and treatment].
    Modrzejewska M
    Ann Acad Med Stetin; 2006; 52(1):73-8; discussion 78. PubMed ID: 17131850
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.